Medical Care Technologies (OTC PINK:MDCE) Advances AI Research to Help Identify Early Health Risks in Skin Cancer, Vision, Wound Care, and Mental Wellness
Medical Care Technologies (OTC PINK:MDCE) on October 9, 2025 highlighted progress in its AI preventive health platform across four verticals: skin health, ocular health, wound monitoring, and mental & behavioral health. The company tied each module to global burden statistics: 60,000+ annual deaths from melanoma and other skin cancers, 100M+ people with vision loss risk from diabetic/vascular eye disease, 5M+ chronic wound/post-surgical infection cases annually, and 700,000+ annual suicide deaths. The release described AI-assisted imaging for earlier detection and a non-clinical emotion-tracking tool for self-monitoring, and reiterated forward-looking risks to development, regulatory and operational outcomes.
CEO emphasized that AI is intended to help reveal early signs but not replace clinicians.
Medical Care Technologies (OTC PINK:MDCE) il 9 ottobre 2025 ha evidenziato progressi nella sua piattaforma di salute preventiva basata sull'IA in quattro settori: salute della pelle, salute oculare, monitoraggio delle ferite e salute mentale e comportamentale. L'azienda ha collegato ogni modulo alle statistiche sul carico globale: oltre 60.000+ decessi annui per melanoma e altri tumori della pelle, 100M+ persone a rischio perdita della vista dovuta a malattie oculari diabetiche/vascolari, 5M+ casi di ferite croniche/infezioni post-operatorie all'anno e 700,000+ suicidi annui. Il comunicato descrive imaging assistito dall'IA per una rilevazione precoce e uno strumento di monitoraggio delle emozioni non clinico per l'autoverifica, e ribadisce i rischi futuri relativi a sviluppo, regolamentazione e risultati operativi.
CEO ha sottolineato che l'IA è destinata ad aiutare a rivelare i segni precoci ma non a sostituire i clinici.
Medical Care Technologies (OTC PINK:MDCE) el 9 de octubre de 2025 destacó avances en su plataforma de salud preventiva basada en IA en cuatro verticales: salud de la piel, salud ocular, monitoreo de heridas y salud mental y conductual. La empresa vinculó cada módulo a estadísticas de carga global: más de 60,000+ muertes anuales por melanoma y otros cánceres de piel, 100M+ personas con riesgo de pérdida de la visión debido a enfermedad ocular diabética/vascular, 5M+ casos de heridas crónicas/infecciones postoperatorias anualmente y 700,000+ suicidios anuales. El comunicado describió imágenes asistidas por IA para detección temprana y una herramienta de seguimiento de emociones no clínica para automonitoreo, y reiteró los riesgos futuros para desarrollo, regulación y resultados operativos.
CEO enfatizó que la IA está destinada a ayudar a revelar señales tempranas, pero no a reemplazar a los médicos.
Medical Care Technologies (OTC PINK:MDCE)은 2025년 10월 9일에 피부 건강, 눈 건강, 상처 모니터링, 정신 및 행동 건강의 네 가지 분야에서 AI 예 Preventive Health 플랫폼의 진전들을 강조했습니다. 회사는 각 모듈을 글로벌 부담 통계와 연결했습니다: 멜라노마 및 기타 피부암으로 인한 연간 사망자 60,000+명 이상, 당뇨/혈관성 안질환으로 인한 시력 상실 위험이 있는 100M+명 이상, 연간 만성 상처/수술 후 감염으로 인한 5M+건 이상, 연간 자살 사망 700,000+명 이상. 보도자료는 조기 발견을 위한 AI 보조 영상과 비임상 감정 추적 도구를 통한 자기 관리, 그리고 개발·규제 및 운영 결과에 대한 향후 위험을 재확인했습니다.
CEO는 AI가 조기 징후를 드러내는 데 도움을 주는 것이지 임상의 대체가 아니라고 강조했습니다.
Medical Care Technologies (OTC PINK:MDCE) le 9 octobre 2025 a mis en évidence les progrès de sa plateforme de santé préventive basée sur l'IA dans quatre domaines: la santé de la peau, la santé oculaire, la surveillance des plaies et la santé mentale et comportementale. L'entreprise a lié chaque module à des statistiques mondiales de charge: plus de 60 000 décès annuels dus au mélanome et à d'autres cancers de la peau, 100M+ de personnes à risque de perte de vision due à une maladie oculaire diabétique/vasculaire, plus de 5M+ cas de plaies chroniques/infections post-opératoires annuellement et plus de 700 000+ suicides annuels. Le communiqué décrit des images assistées par IA pour une détection précoce et un outil de suivi des émotions non clinique pour l'autosurveillance, et réitère les risques futurs liés au développement, à la réglementation et aux résultats opérationnels. Le PDG a souligné que l'IA est destinée à aider à révéler les signes précoces mais à ne pas remplacer les cliniciens.
Medical Care Technologies (OTC PINK:MDCE) hob am 9. Oktober 2025 Fortschritte in seiner KI-basierten Plattform für präventive Gesundheit in vier Bereichen hervorgehoben: Hautgesundheit, Augengesundheit, Wundüberwachung und mentale & Verhaltensgesundheit. Das Unternehmen verknüpfte jedes Modul mit globalen Belastungsstatistiken: über 60.000+ jährliche Todesfälle durch Melanom und andere Hautkrebsarten, 100M+ Menschen mit Risiko eines Sehverlusts durch diabetische/gefäßbedingte Augenkrankheiten, 5M+ jährliche Fälle von chronischen Wunden/postoperativen Infektionen und 700.000+ jährliche Suizide. Die Mitteilung beschrieb KI-unterstützte Bildgebung für frühere Erkennung und ein nicht klinisches Emotions-Tracking-Tool zur Selbstüberwachung sowie die zukünftigen Risiken für Entwicklung, Regulierung und Betriebsergebnisse. Der CEO betonte, dass KI dazu gedacht ist, frühe Anzeichen zu erkennen, aber keine Kliniker zu ersetzen.
Medical Care Technologies (OTC PINK:MDCE) في 9 أكتوبر 2025 أبرزت التقدم في منصتها للصحة الوقائية المعتمدة على الذكاء الاصطناعي عبر أربعة مجالات: صحة البشرة، صحة العين، مراقبة الجروح، والصحة العقلية والسلوكية. ربطت الشركة كل وحدة بإحصاءات العبء العالمي: أكثر من 60,000+ وفاة سنوية من الورم الميلانيني وغيره من سرطانات الجلد، أكثر من 100M+ شخص معرضون لفقدان البصر بسبب أمراض العين السكري/الوعائية، وأكثر من 5M+ حالات جروح مزمنة/عدوى ما بعد الجراحة سنويًا، وأكثر من 700,000+ وفاة انتحار سنويًا. وصفت الإبلاغ التصويري بمساعدة الذكاء الاصطناعي للكشف المبكر وأداة تتبع العاطفة غير الإكلينيكية للمراقبة الذاتية، وأكدت المخاطر المرتبطة بالتطوير والتنظيم والنتائج التشغيلية في المستقبل. وأكد الرئيس التنفيذي أن الذكاء الاصطناعي يهدف إلى المساعدة في كشف العلامات المبكرة ولكنه لا يحل محل الأطباء.
Medical Care Technologies (OTC PINK:MDCE) 于 2025年10月9日 强调了其基于人工智能的预防性健康平台在四个领域的进展：皮肤健康、眼部健康、创口监测、以及 心理与行为健康。公司将每个模块与全球负担统计联系在一起：因黑色素瘤及其他皮肤癌每年死亡超过 60,000+ 例，因糖尿病/血管性眼病导致的视力丧失风险超过 100M+ 人，年创口慢性疾病/术后感染超过 5M+ 例，以及每年自杀死亡超过 700,000+ 例。新闻稿描述了用于早期检测的 AI 辅助成像以及用于自我监测的非临床情绪跟踪工具，并重申了对开发、监管和运营结果的未来风险。CEO 强调，AI 的目的是帮助揭示早期迹象，而非取代临床医生。
- None.
- None.
MESA, ARIZONA / ACCESS Newswire / October 9, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a developer of artificial intelligence-powered preventive health technology, today emphasized the urgent human need driving each vertical of its AI platform - underscoring the global lives lost and affected every year to conditions that may be better managed through earlier detection and awareness.
Skin Health
Over 60,000 people die from melanoma and other skin cancers each year. Many are diagnosed too late. MDCE's dermatology module is designed to help users identify visible irregularities earlier through AI-assisted imaging.
Ocular Health
More than 100 million people worldwide experience vision loss from diabetic and vascular eye diseases. MDCE's ocular imaging system aims to analyze retinal patterns that may signal early changes before irreversible damage occurs.
Wound Monitoring
Over 5 million chronic wound and post-surgical infection cases occur annually, often leading to preventable complications. MDCE's wound module seeks to enable continuous image-based tracking for improved recovery oversight.
Mental & Behavioral Health
More than 700,000 lives are lost to suicide every year. MDCE's non-clinical, AI-assisted mental health tracker uses facial micro-expression and emotion-recognition models to explore patterns tied to stress, fatigue, and emotional decline - supporting greater awareness and self-monitoring.
"These global health statistics remind us why early detection and awareness matter," said CEO Marshall Perkins III. "AI cannot replace doctors, but it can help reveal the unseen - and that visibility can make all the difference."
Safe Harbor Statement
This press release contains forward-looking statements based on current expectations regarding future research, technology development, and business outcomes. Such statements are subject to risks and uncertainties that may cause actual results to differ materially, including technical performance, regulatory changes, and operational challenges. Medical Care Technologies Inc. assumes no obligation to update or revise forward-looking statements except as required by law.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC Pink: MDCE) develops AI-based imaging and biometric technologies to promote early health awareness across dermatology, ocular, wound care, and behavioral health. The company is committed to ethical innovation, data transparency, and responsible AI development.
Visit www.medicalcaretechnologies.com for more information.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
FAQ
What did Medical Care Technologies (MDCE) announce on October 9, 2025?
How does MDCE's dermatology module aim to help detect skin cancer earlier?
What is MDCE's ocular health solution designed to detect for investors following the Oct 9, 2025 announcement?
What capability did MDCE describe for wound monitoring in the October 9, 2025 release?
What did MDCE say about its mental and behavioral health tool on October 9, 2025?
Does the October 9, 2025 release include any regulatory approvals or financial guidance for MDCE?
